Heart failure & cardiomyopathiesResearch article
Disease Prognosis and Progression in Transthyretin Amyloidosis
- Narrative review
Study context
- Population
- Transthyretin amyloidosis (ATTR)
Main finding
As reported in the abstract
Markers of disease prognosis and progression in ATTR (clinical, biomarker, functional and imaging markers of cardiac disease progression)
- Review of current knowledge on disease prognosis and progression in ATTR, focused on clinical, biomarker, functional and imaging markers of cardiac disease progression
- Need for further investigation of neurologic and other noncardiac indicators of disease progression
- Current approaches and future directions for disease monitoring in ATTR discussed
Original publication
Disease Prognosis and Progression in Transthyretin Amyloidosis. JACC CardioOncol. doi:10.1016/j.jaccao.2026.02.004
Summarised from the published abstract; every number is checked against it